The SLAS Fellow Member Program launched in 2016 to recognize the exceptional contributions of SLAS’s most valued contributors. SLAS Fellow Members represent the epitome of SLAS as a mission-driven organization that focuses on serving life sciences professionals via practitioner-driven knowledge, education and peer-to-peer connections.
Join or renew your SLAS Premier Membership to begin your journey to becoming an SLAS Fellow Member.
*Denotes 2024 Fellows
*Elizabeth Admirand
Frontier Medicines
Michelle Arkin, Ph.D.
University of California San Francisco
*Douglas S. Auld, Ph.D.
Novartis for Biomedical Research
Ellen Berg, Ph.D.
Alto Predict
Marc Bickle, Ph.D.
Roche (Institute of Translational Bioengineering)
Manuela Beil-Peter
SOULution
*Matt Boeckeler
AstraZeneca
Roger Bosse, Ph.D.
BioSignal2 Inc.
John Thomas Bradshaw, Ph.D.
JTP Technical Solutions
*Marybeth Burton
Merck
Robert Campbell, Ph.D.
Redona Therapeutics
Anne Carpenter, Ph.D.
Broad Institute of Harvard and MIT
Taosheng Chen, Ph.D.
St. Jude Children’s Research Hospital
Edward Kai-Hua Chow, Ph.D.
National University of Singapore
Sabrina Corazza
Axxam Spa
J. Colin Cox, Ph.D.
Hexagon Bio
Sue Crimmin, Ph.D.
Independent Consultant
Melissa Crisp, Ph.D.
Eli Lilly and Company
Malcolm Crook, Ph.D.
Peak Analysis & Automation Ltd.
*Robert Damoiseaux, Ph.D.
UCLA
Sammy Datwani, Ph.D.
Synthego Corporation
*Timothy Dawes, Ph.D.
Cytokinetics
Emilio Diez Monedero, Ph.D.
Hakim Djaballah, Ph.D.
Keren Therapeutics
Alain Donzel, Ph.D.
Scitec Research S.A.
Richard M. Eglen, Ph.D.
Arsenal Capital Partners
*Jan Eickhoff, Ph.D.
Lead Discovery Center GmbH
Richard Ellson, M.S.
Beckman Coulter Life Sciences
*Kenda Evans, Ph.D.
Agilent Technologies, Inc.
Frank Fan, Ph.D.
Promega Corporation
*Amaury Ernesto Fernández-Montalván, Ph.D.
Boehringer Ingelheim
Ralph Garippa, Ph.D.
Memorial Sloan-Kettering
J. Fraser Glickman, M.S.P.H., Ph.D.
The Rockefeller University
Marcie Glicksman, Ph.D.
EnClear Therapies
Alexander Godfrey, Ph.D.
Automated Chemistry, National Center For Advancing Translational Sciences
Rose Gonzales, Ph.D.
Thames Pharma Partners, LLC
Maciej Grajewski
SG Papertronics B.V.
Peter Grandsard
Amgen
Clive Green, Ph.D.
AstraZeneca
Philip Gribbon, Ph.D.
Fraunhofer ITMP
Steven Hamilton, Ph.D
The Hamilton Consulting Group
David Herold, Ph.D., M.D.
Veterans Administration Medical Center/University of California, San Diego
Dean Ho, Ph.D.
National University of Singapore
Geoffrey Holdgate
AstraZeneca
Kamran Honarnejad, Ph.D.
Evotec
Rob Howes, Ph.D.
Charles River Laboratories
*Stephen Hughes, Ph.D.
Genscript
William Janzen, Ph.D.
Janzen Consulting
David Jennions, Ph.D.
GRAIL
*Joshua D. Kangas, Ph.D.
Carnegie Mellon University
Katy Kettleborough
LifeArc
Deok-Ho Kim, Ph.D.
University of Washington
Gary Kramer, Ph.D.
Eberhard Krausz, Ph.D.
Evotec
Jörg Kutter, Ph.D.
University of Copenhagen
Jonathan A. Lee, Ph.D.
PDD4Patients
Melanie Leveridge
GlaxoSmithKline
Jan Lichtenberg, Ph.D.
InSphero
Andreas H. Luippold, Ph.D.
Boehringer Ingelheim Pharma GmbH & Co. KG
Ricardo Macarron, Ph.D.
InCyte
Julio Martin, Ph.D.
Lorenz Mayr, Ph.D.
Mayr Biotech Consulting
*Duncan J. McNicol
Merck
*Georges Muller, Ph.D.
SEED Biosciences Ltd.
Coleman Murray
Ferrologix
Kristen Nailor
Genentech
Andrew Napper, Ph.D.
Bristol Myers Squibb
Jonathan O'Connell, Ph.D.
Dewpoint Therapeutics
Christian Parker, Ph.D.
Novartis Biomedical Research
David Pechter, Ph.D.
Pechter Technologies
Oliver Peter
Isorsia Pharmaceuticals, Ltd.
Yohann Potier, Ph.D.
Tessera Therapeutics
Shalini Prasad, Ph.D.
University of Texas, Dallas
Stephen Rees, Ph.D., O.B.E.
AstraZeneca
Mario Richter
Abbvie
Terry Riss, Ph.D.
Promega
Mark Russo, Ph.D.
The College of New Jersey
Mariafrancesca Scalise, Ph.D.
University of Calabria
Louis Scampavia, Ph.D.
Scripps Research
Burkhard Schaefer
Splashlake
Craig Schulz, Ph.D.
Terray Therapeutics
*Per Setterberg
Iscaffpharma
Ian Shuttler, Ph.D.
Ian Shuttler Consultancy Ltd.
Peter Simpson, Ph.D.
Vitarka Therapeutics
Daniel Sipes, M.S.
Plexium
G. Sitta Sittampalam
NIH/NCATS
Timothy Spicer, Ph.D.
The Scripps Research Institute
James D. Sterling, Ph.D.
Keck Graduate Institute
Kim Titus
Corning Life Sciences
Cathy Tralau-Stewart, Ph.D.
Milner Therapeutics Insititute
Dana Vanderwall, Ph.D.
Bristol-Myers Squibb
Steven P. van Helden
wega Informatic AG
Sabeth Verpoorte, Ph.D.
University of Groningen
Fabien Vincent, Ph.D.
Pfizer
Andrea Weston, Ph.D.
Pfizer
Mary Jo Wildey, Ph.D.
Merck
Jonathan Wingfield, Ph.D.
AstraZeneca
Pak Kin Wong, Ph.D.
Pennsylvania State University
Andy Zaayenga
SmarterLab
Zhenggrong Zhu, Ph.D.
Merck
*Adam Zweifach, Ph.D.
University of Connecticut
To earn an invitation to become an SLAS Fellow Member, candidates must meet several prerequisites:
See the table below for engagement point values associated with content and service contributions.
In addition to well-deserved and prestigious recognition, SLAS Fellow Members receive a host of exclusive benefits:
SLAS Fellow Members are required to pay SLAS membership dues annually.
Please contact Gina Anzalone, SLAS Membership Manager, with any questions or to check your current eligibility toward becoming an SLAS Fellow Member.
5 total points, with at least one from content contribution and one from volunteer service activities, are required to earn an invitation to become an SLAS Fellow Member. Questions on your current status? Contact Mary Geismann at SLAS Headquarters.
Content – Technical Presentations (1 point per) | Content – Journal Manuscripts or Issue Guest Editor (2 points per) | Service – Volunteer Leadership (2 points per role) |
---|---|---|
|
|
Served volunteer leadership position in significant SLAS committee/ oversight entity:
|